Unknown statusInterventionalPhase 1Last updated Jul 23, 2010

Treatment of Severe Limb Ischemia With Autologous Bonemarrow Derived Mononuclear Cells

Overview

ClinicalTrials.gov ID: NCT00442143
Lead Sponsor: Odense University HospitalOTHER
Brief Summary: The aim of the study is to investigate whether implantation of autologous bone marrow derived stem cells in ishemics limbs will improve vascularization
Study Type: Interventional

Status

Study Record Dates

NCT00371371Completed

Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI)

NCT00539266Unknown status

Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia

NCT00872326Completed

Autologous Bone Marrow Derived Mononuclear Cells in Treating Diabetic Patients With Critical Limb Ischemia

NCT00919516Completed

Autologous Bone Marrow Mononuclear Cell Implantation for Moderate to Severe Peripheral Arterial Disease

NCT01472289Completed

Safety and Efficacy of Autologous Bone Marrow Mononuclear Cells in Patients With Severe Critical Limb Ischemia

NCT00904501Completed

Bone Marrow Autograft in Limb Ischemia